Microbial Products Market Size, Growth, Share, Trend, Latest Insights, Future Trends and Forecast till 2030

 

Global Microbial Products Market - Highlights

Microbial products are produced by microbes such as a bacteria, yeast, or fungus. Medicinal microbiology includes production of enzymes, antibiotics, nutrients such as amino acids, vitamins, and organic acids, chemotherapeutic agents, vaccines etc. Some of the applications of microbial products are manufacturing of solvents and reagents such as ethanol, lactic acid, butanol etc. Synthesis of amino acids such as are L-Methionine, L-Lysine, L-Tryptophan, L-Glutamic acid etc. are another use of industrial microbiology for production of microbial products.

On the other hand, there are certain hurdles for the growth of this market. The highly fragmented nature of the industry, pressures on profits due to cutthroat competition, secrecy surrounding the fermentation process, substandard low-quality producers operating from unknown locations are some of the factors that may hinder the growth of the microbial products market soon.

According to a recent study published by the Market Research Future analysts, the microbial products market size is expected to reach USD 1,910 Million by 2030 at 6.20% CAGR during the forecast period 2022-2030. The market for microbial products is driven mainly due to growing prevalence of diseases, rising demand for healthcare nutrients such as vitamins, rising rates of cancers, rising demand for diagnostics microbial products, rise of lifestyles industry recommending many of these products etc.

Microbial Products Global Market   - Segmentation

The Microbial Products Market outlook can be segmented in to 3 key dynamics for the convenience of the report and enhanced understanding.

Segmentation By Application             : Comprises In Agriculture (Pesticides- Bacteria, Protozoa, Fungi, Nematodes, Fertilizers- Nitrogen bio fertilizers, phosphorus bio fertilizers), In Healthcare (Microbial Biopharmaceuticals, Therapeutics), In Manufacturing (Food Processing, Enzymes, Biopolymers), In Energy (Biofuels, Microbial-Enhanced Oil Recovery, Microbial Fuel Cells, Hydrogen Production),  In Environment (Environmental monitoring, Bioremediation, Recycling, Oil Spills & Residues Clean-up Wastewater & Sewage Treatment)

Segmentation By End Users                : Comprises Healthcare, Manufacturing, Agriculture, and Energy, Environment and other and other.

Segmentation By Regions                   : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Global Microbial Products Market - Regional Analysis

European market is second highest revenue generator after North America. Europe microbial products market has benefited by the presence of some major players in this region. Moreover, increasing innovation and changing laboratory practices are driving the growth for Europe microbial products market.

In 2016, North America and Europe were holding more than half market share of global microbial products market. Increasing funding for R&D is major driving force for the market growth. The funding for microbiology research in US is one of the highest as compared to other countries. Rapid adoption of advanced products and techniques are driving the growth for North America market. Increasing demand for high quality reagents, and solvents for the use in performing various rapid microbial testing are promoting the research related activities in this region. Independent laboratories are dominating the North America market by adopting new technologies and trends.

Microbiology products have huge and increasing demand not only in developed countries but also in developing countries like India & China. The presence of unmet medical needs and the growing industrial demand are the strongest driver for the growth in these markets. Thus, there is larger potential to grow in the developing regions due to less competition. The growing number of biotech firms and the growing demand for high quality solvents to satisfy the industrial base will drive the future market.

The Middle East and Africa microbial products market is growing gradually with the development in the research. Moreover, developing healthcare infrastructure in some of the countries like UAE, Saudi Arabia, Oman, South Africa have helped the growth of the overall healthcare segment also including the microbial products. However, there are some factors are affecting the microbial products market in this region such as, limited access to the healthcare facilities in underdeveloped parts, lack of knowledge of new microbial products, less market penetration by companies, and limited availability of products etc. Currently Middle East & Africa region contributes least in the global microbial products market.

Global Microbial Products Market Players

Microbial products market players are Amgen Inc., Merck & Co., Inc., Valent BioSciences Corp., GlaxoSmithKline plc, Pfizer Inc., bioMérieux SA, Ajinomoto Co.Inc., Sanofi S.A, Novartis AG, NovaDigm Therapeutics, Kyowa Hakko Bio Co., Ltd. and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Acute Care EHR Market Focuses on SWOT analysis, Synopsis, Development Plans 2020 to 2027

  Overview The acute care EHR slightly differ from the hospital and ambulatory EHR, generating patient information with all clinical details including the operating room, emergency department, ICU, and inpatient unit. Over the past decade, there has been a significant rise in the number of patients suffering from chronic diseases such as cancer, diabetes, heart disease, and stroke among others which are driving the acute care EHR market, increasing the number of caregiving facilities across the globe. Recognizing the exponential growth, the market perceives currently and gauging the potential the market holds to grow in the years to come; Market Research Future (MRFR), in its recently published market forecast asserts that the global  acute care EHR market  will grow exponentially by 2023, registering approximately 7% CAGR during the forecast period (2020 – 2027). The global acute care EHR is majorly driven by the augmenting demand for the remote health monitoring for geriatric patient
Read more

mHealth Market Latest Study Focuses On Current, Future Innovations and Top Key Vendors | Forecast 2030

  Market Overview The wave of modernization in the healthcare sector has led to the penetration of the concept of mHealth greatly. Reports that gauge the healthcare IT industry has been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is forecasted to achieve a 36.5% CAGR in the upcoming forecast period. The robust growth pace in the wearable health device sector has increased the expansion of the  mHealth market  globally. Moreover, increased usage of smartphones is also playing a key role in the growth of the market. Also, patients are increasingly involved and aware of their treatments which is expected to further influence the mHealth market in the forecast period. Segmental Analysis The segmental evaluation of the mHealth market is carried out on the basis of therapeutics, applications, and region. On the basis of therapeutics, the mHealth market has been segmented into respiratory,
Read more

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth, Opportunity and Product Developments 2030 |MRFR

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device ma rket . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Regional Analysis The market in the Americas is expected to dominate t
Read more